The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 03, 2025
Filed:
Sep. 07, 2023
Applicant:
Curevac SE, Tübingen, DE;
Inventors:
Susanne Rauch, Tübingen, DE;
Benjamin Petsch, Tübingen, DE;
Assignee:
Cure Vac SE, Tübingen, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 9/00 (2006.01); A61K 39/12 (2006.01); A61K 39/15 (2006.01); A61P 31/14 (2006.01); C07K 14/005 (2006.01); C12N 15/113 (2010.01); C12N 15/62 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/15 (2013.01); A61K 9/0019 (2013.01); A61K 39/12 (2013.01); A61P 31/14 (2018.01); C12N 15/113 (2013.01); C12N 15/62 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/53 (2013.01); C12N 2720/12334 (2013.01);
Abstract
The present invention provides mRNA sequences comprising at least one coding region, encoding for at least one epitope of a protein, or of a fragment, variant or derivative thereof, of a virus of the genus rotavirus. Particularly preferred is the protein respectively the protein cleavage product VP8* of rotavirus. The mRNA sequence may be used as a vaccine or generally as a pharmaceutical composition for prophylaxis or treatment of rotavirus infections.